Skip links

Understanding the 505(b)(2) Approval Pathway


Explore how the 505(b)(2) regulatory pathway can help drug developers gain approval for new drugs in a fraction of the time and cost required by traditional paths.

 

We’ll answer questions like:

  • What is a 505(b)(2) new drug application and how does it differ from the 505(b)(1) process?
  • What key regulatory, safety, and CMC challenges exist with 505(b)(2) NDA submissions?
  • Is an IND required to initiate studies in 505(b)(2) development?

Download the White Paper

  • This field is for validation purposes and should be left unchanged.